Trial record 2 of 8 for:    Reduce-It

Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software (SEDDI)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Universidad Nacional de Córdoba.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Universidad Nacional de Córdoba
ClinicalTrials.gov Identifier:
NCT00850330
First received: February 20, 2009
Last updated: August 3, 2009
Last verified: August 2009
  Purpose

A drug interaction (DI) is the mutual action of two drugs in a way that they can increase their action, even to a toxic level, or reduce it to its minimum.

People elder than 65 years old have theirs biological ability to metabolized and eliminate drugs impaired. Even more, they tend to suffer from many diseases, are treated for many physicians, and receive many drugs for those conditions. If hospitalized older people are prone to receive a greater number of drugs. This scenario is the worst to suffer from adverse drug events and DI, which in turn compromise more the health and even life of hospitalized older people.

Many computerized strategies have been developed to prevent those problems. In this trial the investigators use on line software to early detect DI that could endanger health or life of hospitalized older patients.


Condition Intervention
Drug Interactions
Other: on line software to detect DI early on

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Transversal, Multicentric Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software in Córdoba, Argentina

Resource links provided by NLM:


Further study details as provided by Universidad Nacional de Córdoba:

Primary Outcome Measures:
  • Early detect DI in hospitalized elder patients [ Time Frame: One year and 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 3000
Study Start Date: June 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Hospitalized patients
Patients elder than 65 years old hospitalized for any reason.
Other: on line software to detect DI early on
Patients hospital records will be reviewed on the day of admission to assess all their indication using on line software to early detect drug interactions.
Other Names:
  • Software are available on:
  • http://www.medscape.com/druginfo/druginterchecker
  • http://www.medicamentosrothlin.com.ar/

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Hospitalized patients older than 65 years old

Criteria

Inclusion Criteria:

  • Hospitalization
  • 65 years old or more

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00850330

Contacts
Contact: Gabriel S Iraci, MD, Prof 54 0351 489 9454 gabysi_01@yahoo.com
Contact: Hilda L Montrul, MD, Prof 54 0351 4337033 hmontrull@fibertel.com.ar

Locations
Argentina
Hospital Nacional de Clínicas Not yet recruiting
Cordoba, Argentina, x5009
Contact: Gabriel S Iraci, MD, Prof    54 0351 489 9454    gabysi_01@yahoo.com   
Clínica Privada Colombo Recruiting
Córdoba, Argentina, x5000
Contact: Marcelo Dellatorre, M.D.    543514891398    secretaria@fundcolombodiaz.org.ar   
Sub-Investigator: Herminia Cesca, M.D.         
Sponsors and Collaborators
Universidad Nacional de Córdoba
Investigators
Principal Investigator: Gabriel S Iraci, MD, Prof Catedra de Farmacología, Hospital Nacional de Clínicas, Universidad Nacional de Córdoba
  More Information

Additional Information:
Publications:

Responsible Party: Gabriel Santino Iraci, Catedra de Farmacología. Hospital Nacional de Clínicas. Universidad Nacional de Cordoba
ClinicalTrials.gov Identifier: NCT00850330     History of Changes
Other Study ID Numbers: Iraci-01
Study First Received: February 20, 2009
Last Updated: August 3, 2009
Health Authority: Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica

Keywords provided by Universidad Nacional de Córdoba:
Drug interactions
Drug interaction software
Older patients
Hospitalization

ClinicalTrials.gov processed this record on September 16, 2014